Search results
Neil Powe and Cynthia Delgado
Time Magazine· 2 days agoBack in 1998, an African-American researcher published a key finding that levels of a protein called creatinine tended to be higher in Black patients...
What a Basic Metabolic Panel (BMP) Measures
Verywell Health via Yahoo News· 4 days agoThey are: Bicarbonate (electrolyte form of carbon dioxide) Blood urea nitrogen (BUN) Calcium Chloride Creatinine Glucose Potassium Sodium Following are...
What Happens To Your Body When You Take Creatine
Verywell Fit via Yahoo News· 5 days agoCreatine is one of the most well-studied supplements used for muscle growth and enhanced athletic performance. What exactly does it do in the body to...
Cytokine Release Syndrome: What to Know
Verywell Health via Yahoo News· 2 days agoCytokine release syndrome (CRS) occurs when the immune system responds to infection or immunotherapy drugs more aggressively than it should. Learn more...
CYNTHIA DELGADO AND NEIL POWE NAMED TO TIME100 HEALTH LIST FOR FIGHTING KIDNEY TRANSPLANT BIAS
Bennington Banner· 1 day agoTIME has included the co-chairs of the National Kidney Foundation (NKF)/ American Society of Nephrology (ASN) Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases, among ...
Thousands of Black patients moved up the national kidney transplant waitlist after new, race-neutral...
13 News, WVEC Hampton Roads· 3 days agoAfter a series of tests, doctors told Norris he had pneumonia. "They did [an] ultrasound on my...
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 2 days agoCommercial launch of INPEFA® (sotagliflozin) for Heart Failure continues to progress Resubmission of NDA for ZYNQUISTA™ (sotagliflozin) in Type 1 Diabetes expected mid-year 2024 Start-up ongoing ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement clears path for launch of Jubbonti® and Wyost
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include...
Morningstar· 4 days agoThe U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program New data showing sustained complete renal response with LUPKYNIS through three years Monthly kidney
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoAllschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that
